399 related articles for article (PubMed ID: 29540832)
1. miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy.
Xi J; Huang Q; Wang L; Ma X; Deng Q; Kumar M; Zhou Z; Li L; Zeng Z; Young KH; Zhang M; Li Y
Oncogene; 2018 Jun; 37(23):3151-3165. PubMed ID: 29540832
[TBL] [Abstract][Full Text] [Related]
2. miR-375 inhibits IFN-γ-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.
Wu Q; Zhao Y; Sun Y; Yan X; Wang P
Oncol Rep; 2018 Mar; 39(3):1461-1468. PubMed ID: 29328389
[TBL] [Abstract][Full Text] [Related]
3. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
Gray MJ; Gong J; Hatch MM; Nguyen V; Hughes CC; Hutchins JT; Freimark BD
Breast Cancer Res; 2016 May; 18(1):50. PubMed ID: 27169467
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitor induces cardiac injury through polarizing macrophages via modulating microRNA-34a/Kruppel-like factor 4 signaling.
Xia W; Zou C; Chen H; Xie C; Hou M
Cell Death Dis; 2020 Jul; 11(7):575. PubMed ID: 32709878
[TBL] [Abstract][Full Text] [Related]
6. PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors.
Seifert AM; Zeng S; Zhang JQ; Kim TS; Cohen NA; Beckman MJ; Medina BD; Maltbaek JH; Loo JK; Crawley MH; Rossi F; Besmer P; Antonescu CR; DeMatteo RP
Clin Cancer Res; 2017 Jan; 23(2):454-465. PubMed ID: 27470968
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.
Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L
Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506
[TBL] [Abstract][Full Text] [Related]
8. The role of the PD-1/PD-L1 axis in macrophage differentiation and function during pregnancy.
Zhang Y; Ma L; Hu X; Ji J; Mor G; Liao A
Hum Reprod; 2019 Jan; 34(1):25-36. PubMed ID: 30500923
[TBL] [Abstract][Full Text] [Related]
9. MiR-16 regulates mouse peritoneal macrophage polarization and affects T-cell activation.
Jia X; Li X; Shen Y; Miao J; Liu H; Li G; Wang Z
J Cell Mol Med; 2016 Oct; 20(10):1898-907. PubMed ID: 27241533
[TBL] [Abstract][Full Text] [Related]
10. miR-146a Controls Immune Response in the Melanoma Microenvironment.
Mastroianni J; Stickel N; Andrlova H; Hanke K; Melchinger W; Duquesne S; Schmidt D; Falk M; Andrieux G; Pfeifer D; Dierbach H; Schmitt-Graeff A; Meiss F; Boerries M; Zeiser R
Cancer Res; 2019 Jan; 79(1):183-195. PubMed ID: 30425059
[TBL] [Abstract][Full Text] [Related]
11. Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases.
Dhupkar P; Gordon N; Stewart J; Kleinerman ES
Cancer Med; 2018 Jun; 7(6):2654-2664. PubMed ID: 29733528
[TBL] [Abstract][Full Text] [Related]
12. Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer.
He S; Song W; Cui S; Li J; Jiang Y; Chen X; Peng L
Cell Oncol (Dordr); 2023 Dec; 46(6):1731-1746. PubMed ID: 37402945
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression.
Xu P; Xiong W; Lin Y; Fan L; Pan H; Li Y
Cell Death Dis; 2021 Aug; 12(8):779. PubMed ID: 34365463
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1-TINCR-USP20-PD-L1 axis.
Wang Q; Li G; Ma X; Liu L; Liu J; Yin Y; Li H; Chen Y; Zhang X; Zhang L; Sun L; Ai J; Xu S
Cell Death Dis; 2023 Feb; 14(2):76. PubMed ID: 36725842
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
[TBL] [Abstract][Full Text] [Related]
16. [Paeonol inhibits macrophage M1 polarization by down-regulating miR-155/JAK1-STAT1 pathway].
Sun Y; Liu L; Shi XY; He H; Huang HW; Dai M
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(9):2158-2164. PubMed ID: 32495566
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan.
Chen W; Wang J; Jia L; Liu J; Tian Y
Cell Death Dis; 2016 Feb; 7(2):e2115. PubMed ID: 26913605
[TBL] [Abstract][Full Text] [Related]
18. JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer.
Chen M; Pockaj B; Andreozzi M; Barrett MT; Krishna S; Eaton S; Niu R; Anderson KS
Clin Breast Cancer; 2018 Oct; 18(5):e1205-e1215. PubMed ID: 29933930
[TBL] [Abstract][Full Text] [Related]
19. A Novel Kinase Inhibitor AX-0085 Inhibits Interferon-γ-Mediated Induction of PD-L1 Expression and Promotes Immune Reaction to Lung Adenocarcinoma Cells.
Kim J; Jang H; Lee GJ; Hur Y; Keum J; Jo JK; Yun SE; Park SJ; Park YJ; Choi MJ; Kim KS; Kim J
Cells; 2021 Dec; 11(1):. PubMed ID: 35011581
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-150 deficiency accelerates intimal hyperplasia by acting as a novel regulator of macrophage polarization.
Qiu M; Ma J; Zhang J; Guo X; Liu Q; Yang Z
Life Sci; 2020 Jan; 240():116985. PubMed ID: 31647949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]